ISPOR - Marketing Authorization of Medicines Approved In Eu Via “Adaptive Pathway”- Consequences on The Egyptian Public Health

Full Text

Marketing Authorization of Medicines Approved In Eu Via “Adaptive Pathway”- Consequences on The Egyptian Public Health

Abstract

Authors

S.R. Ibrahim

Back to Volume 19, Issue 3

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now